Charles Russell Speechlys advises Iceni Capital and other selling shareholders on the sale of StockWell Communications
Charles Russell Speechlys has advised Iceni Capital and other selling shareholders of StockWell Communications, the international strategic communications and reputation management firm, on its sale to Teneo Holdings.
Following its acquisitions of StockWell and Blue Rubicon, Teneo will be one of the largest strategic communications practices in the European market.
All members of StockWell’s senior management team, including Managing Partners Tim Burt, Philip Gawith and Richard Holloway, will continue as part of the Teneo leadership team.
The Charles Russell Speechlys team was led by Private Equity Partner Andrew Clarke and Private Equity Senior Associate Richard Coleman.
Commenting on the transaction, Julian Hanson-Smith, the Chairman of StockWell Communications, said: “Andrew and Richard have advised StockWell Communications and its shareholders since its inception in 2010…The team at Charles Russell Speechlys again provided the vendor shareholders with valuable guidance and support throughout the transaction process, and managed to balance the interests of all parties. "
News & Insights
Charles Russell Speechlys advises Kreos on growth capital investment in JenaValve Technologies, Inc.
Charles Russell Speechlys advised Kreos on its growth capital investment in a biotech company, JenaValve Technologies, Inc.
Charles Russell Speechlys advises Duke Royalty Limited (AIM: DUKE) on £30 Million Debt Facility from Honeycomb Investment Trust PLC
Charles Russell Speechlys advised Duke Royalty Limited on a new £30m revolving credit facility agreement.
British Private Equity Awards 2019: Charles Russell Speechlys team shortlisted for Law Firm of the Year
The Private Equity team has been shortlisted for the Law Firm of the Year – Transactions category at the British Private Equity Awards 2019.
Charles Russell Speechlys advises FPE Capital on its investment in Kallik
Kallik is a leading provider of Labelling and Artwork Management SaaS solutions to the Medical Device, Pharmaceutical and Chemicals sectors.